Header Logo

Connection

Kyle Amber to Pemphigoid, Bullous

Back to Details
This is a "connection" page, showing publications Kyle Amber has written about Pemphigoid, Bullous.
Kyle Amber
Connection Strength
9.401
Pemphigoid, Bullous
  1. Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. Br J Dermatol. 2023 Dec 20; 190(1):137-138.
    View in: PubMed
    Score: 0.866
  2. Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340.
    View in: PubMed
    Score: 0.841
  3. Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 2022; 13:912876.
    View in: PubMed
    Score: 0.783
  4. The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212.
    View in: PubMed
    Score: 0.756
  5. Gene expression profiling of laminin a3-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp Dermatol. 2022 04; 31(4):615-621.
    View in: PubMed
    Score: 0.751
  6. Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022 Nov; 314(9):921-928.
    View in: PubMed
    Score: 0.729
  7. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug; 21(4):557-565.
    View in: PubMed
    Score: 0.685
  8. Eosinophils in bullous pemphigoid. Panminerva Med. 2021 Sep; 63(3):368-378.
    View in: PubMed
    Score: 0.679
  9. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019 May; 18(5):526-534.
    View in: PubMed
    Score: 0.621
  10. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol. 2018 Feb; 54(1):26-51.
    View in: PubMed
    Score: 0.576
  11. Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma. J Dtsch Dermatol Ges. 2018 Feb; 16(2):196-198.
    View in: PubMed
    Score: 0.576
  12. A case report of bullous pemphigoid associated with a melanoma and review of the literature. Melanoma Res. 2017 02; 27(1):65-67.
    View in: PubMed
    Score: 0.538
  13. Is anti-BP180 IgE associated with clinical phenotype? A reply to 'Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid'. Arch Dermatol Res. 2016 Jan; 308(1):65-6.
    View in: PubMed
    Score: 0.495
  14. Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study. Arch Dermatol Res. 2022 Jan; 314(1):77-83.
    View in: PubMed
    Score: 0.179
  15. The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021 03; 30(3):304-318.
    View in: PubMed
    Score: 0.175
  16. Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.